Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07001332 · ClinicalTrials.gov registry record · NA
ELEVATE High-Risk PCI Pivotal Study
A NA study of High-Risk Percutaneous Coronary Intervention (High-risk PCI), sponsored by Magenta Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 290
- Enrollment target
- 20
- Study locations
NCT07001332 is a NA study of High-Risk Percutaneous Coronary Intervention (High-risk PCI) that is actively recruiting participants, run by Magenta Medical. The registered enrollment target is 290 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT07001332, a NA study of High-Risk Percutaneous Coronary Intervention (High-risk PCI), is actively recruiting participants, sponsored by Magenta Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
- 20
- Study locations
Study Summary
The ELEVATE III Pivotal Study is a prospective, multi-center, open-label, interventional, randomized, controlled study with an active control group. The study is intended to assess the safety and efficacy of the Elevate™ percutaneous Left Ventricular Assist Device System in patients referred to high-risk percutaneous coronary interventions (HR-PCI).
Conditions Studied
Interventions
- DEVICE Impella
- DEVICE Elevate
Study Locations (20)
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham & Women's Hospital - Boston
- Boston Medical Center - Boston
- Beth Israel Deaconess Medical Center - Boston
- UMass Memorial Medical Center - Worcester
New York
- Northwell- South Shore University Hospital - Bay Shore
- Maimonides Health - Brooklyn
- Buffalo General Medical Center - Buffalo
- North Shore University Hospital - Manhasset
New Jersey
- Atlantic Health System - Morristown
- Robert Wood Johnson University Hospital - New Brunswick
Arizona
- HonorHealth Scottsdale Shea Medical Center - Scottsdale
California
- University of California at San Francisco Medical Center - San Francisco
Florida
- Tampa General/USF - Tampa
Georgia
- Wellstar Health System - Marietta
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2025-07-25 |
| Est. Completion | 2027-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07001332
The ClinicalTrials.gov registry entry for NCT07001332 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Magenta Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with High-Risk Percutaneous Coronary Intervention (High-risk PCI) appearing as the primary indexed condition, and to 2 interventions - of which Impella is the first listed.
NCT07001332 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Massachusetts, New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT07001332 about?
NCT07001332 is a clinical study titled "ELEVATE High-Risk PCI Pivotal Study". The ELEVATE III Pivotal Study is a prospective, multi-center, open-label, interventional, randomized, controlled study with an active control group. The study is intended to assess the safety and efficacy of the Elevate™ percutaneous Left Ventricular Assist Device System in patients referred to high...
What is the current status of trial NCT07001332?
This trial is currently recruiting. It is a NA study. The enrollment target is 290 participants. The study started on 2025-07-25. Estimated completion is 2027-09-16.
What conditions does trial NCT07001332 study?
This clinical trial studies the following conditions: High-Risk Percutaneous Coronary Intervention (High-risk PCI).
What interventions are being tested in trial NCT07001332?
The interventions under investigation include: Impella (DEVICE), Elevate (DEVICE).
Who is sponsoring clinical trial NCT07001332?
This trial is sponsored by Magenta Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07001332 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.